Here you will find a summary of EyePoint Pharmaceuticals' latest financial information. Latest Earnings Release and 10-Q Show all Fourth Quarter Financial Results 55.4 KB Form 10-Q Latest Annual Report and 10-K Show all 2023 Form 10-K 1.8 MB Latest Proxy Statement Form Filing date View DEF 14A Oct 13, 2009 View HTML 0001193125-09-206670.pdf Share Related Items Market Capitalization (Mil) $844.63 Shares Outstanding (Mil) 49.83 Shares Outstanding, Average (FY) (Mil) 38.90 Float (Mil) 48.73 FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months. Copyright Refinitiv